Spermatogenesis originates from a small population of spermatogonial stem cells. These cells are believed to divide infinitely and support spermatogenesis throughout life in the male. In this investigation, we examined the possibility of deriving transgenic offspring from single spermatogonial stem cells. Spermatogonial stem cells were transfected in vitro with a plasmid vector containing a drug resistant gene. Stably transfected stem cell clones were isolated by in vitro drug selection; these clones were expanded and used to produce transgenic progeny following spermatogonial transplantation into infertile recipients. An average of 49% of the offspring carried the transgene, and the recipient mice continued to produce monoclonal transgenic progeny a year after transplantation. Thus, a somatic cell-based genetic approach can be used to modify and select clones of spermatogonial stem cells in a manner similar to embryonic stem cells. The feasibility of genetic selection using postnatal spermatogonial stem cells demonstrates their extensive proliferative potential and provides the opportunity to develop new methods for generating stable animal transgenics or for germline gene therapy.
INTRODUCTION
Spermatogenesis can be divided into three phases: mitotic expansion of spermatogonia, meiotic diversification in spermatocytes, and maturation into spermatozoa to acquire mobility. At the foundation of this sophisticated process are the spermatogonial stem cells [1, 2] . Because of their unique ability to self-renew, these cells are considered to proliferate infinitely and support spermatogenesis throughout life [3] . Thus, spermatogonial stem cells are the only stem cells in the postnatal animal that can transmit genetic information to the offspring, and transduction of spermatogonial stem cells would produce numerous transgenic sperm, providing a new approach for animal transgenesis [4, 5] . However, there is little evidence that supports the infinite proliferative potential of spermatogonial stem cells, and it has not been possible to modify the genome of sper- Financial support for this research was provided by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. matogonial stem cells in a manner similar to embryonic stem (ES) cells [6] [7] [8] [9] .
Recently, we described a method to expand mouse spermatogonial stem cells in vitro [10] . In this culture system, gonocytes isolated from neonatal mouse testis proliferated logarithmically over a 5-mo period (Ͼ10 14 -fold expansion in stem cell number) in the presence of glial cell line-derived neurotrophic factor (GDNF), leukemia inhibitory factor (LIF), epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF) on mitomycin C-inactivated mouse embryonic feeder cells. These cells were proved to retain stem cell activity by transplantation into seminiferous tubules of the testes, and donor cell haplotype was transmitted to the progeny by mating the recipient animals that underwent transplantation of the cultured cells. Based on these facts, we designated the cultured cells as germline stem cells or GS cells. In addition to ES and embryonic germ (EG) cells that are derived from embryonic cells [11] [12] [13] [14] , GS cells represent a new target for the expansion and manipulation of germline cells.
Since stem cells are considered to be able to proliferate infinitely, in vitro transduction and expansion/selection of transfected stem cell clones comprise the central techniques in manipulating stem cells. Although reconstitution of an entire self-renewing tissue from single stem cells was previously reported in the hematopoietic system [15] , in vitro clonal selection of stem cells remains to be a major challenge in stem cell technology. In this investigation, we examined the feasibility of in vitro selection of spermatogonial stem cells using GS cell culture system. A plasmid vector that contains both enhanced green fluorescent protein (EGFP) marker and drug selection genes were transfected, and GS cell clones were selected in vitro for clonal offspring production.
MATERIALS AND METHODS

Culture of GS Cells
Neonatal testis cells were collected from newborn DBA/2 mice (purchased from Japan SLC, Shizuoka, Japan) by two-step enzymatic digestion [16] . A total of three mice were used to establish GS cells and used in the present study. The dissociated cells were cultured overnight on a 0.2% gelatin-coated plate to remove somatic cells. GS cells were established according to the previously published protocol [10] , and early passage (8 to 13 passages) GS cells were used for experimental studies. All GS cell clones were established from a GS cell culture derived from a total of three mice through three independent transfection experiments. Transfection was performed when more than 70% of GS cell colonies attached to the feeder cells.
Transfection of GS cells
Single cell suspension of GS cells was obtained by treatment with 0.25% trypsin (Invitrogen, Carlsbad, CA), and used for all transfection experiments. The plasmid vector used for the transfection was based on the pCX vector [17] , which carries a neo cassette consisting of a neo- mycin-resistant gene driven by a synthetic mutant polyoma-enhanced HSVtk1 promoter (MC1) [18] (gift from Dr. T. Honjo, Kyoto University, Kyoto, Japan). The cDNA encoding the EGFP gene (Clontech, Palo Alto, CA) was inserted in the Xho I site of the vector under the control of the CAG promoter (pCAG-EGFP2). For electroporation, 10 7 GS cells were suspended in 0.5 ml PBS and mixed with 20 g DNA. Cells were then exposed to a single 320 V, 200-F pulse using the BioRad Gene Pulser II (0.4 cm gap cuvette; BioRad, Hercules, CA). Cells were incubated for 10 min on ice and then plated at a density of 10 5 cells/cm 2 on embryonic fibroblast feeder cells. For calcium phosphate-mediated and DEAE-dextran-mediated transfections, GS cells were transduced with the CellPhect transfection kit (Amersham Biosiences, Piscataway, NJ), according to the manufacturer's instructions. For lipofection, FuGENE 6 transfection reagent (Roche Diagnostics, Tokyo, Japan) was used according to the manufacturer's instructions. GS cells that had been transfected with the plasmid vector were cultured on a G418-resistant mouse embryonic fibroblast feeder layer at a density of 10 5 cells/cm 2 . On the third day after transfection, the expression of the EGFP gene was examined using either a fluorescence microscope or an FACS-Calibur system (BD Biosciences, Franklin Lakes, NJ) as described [19] . In brief, cultured cells were incubated with 0.25% trypsin for 5 min, and then were subjected to vigorous pipetting. The collected cells were suspended in PBS supplemented with 1% fetal calf serum. Cells were kept in the dark on ice until analysis. At least 10 000 events were acquired for each sample. Survival rate after transfection was determined by trypan blue exclusion. To minimize the effect of cell proliferation, we plated the same number of GS cells without treatment, and took the ratio to normalize the survival rate.
Expansion of GS cells
For clonal expansion, GS cells were transduced with FuGENE 6 transfection reagent. Dissociated GS cells were plated at a density of 2 ϫ 10 6 cells/55 cm 2 with 7 ml medium and cultured with 9 g DNA and 27 l FuGENE 6. Cells were maintained for 3 wk after transfection, and then G418 selection (0.2-0.4 mg/ml Geneticin, Invitrogen) was performed 2 days after the passage on G418 resistant embryonic fibroblast feeder cells. Ten days after selection with G418, single colonies were picked and transferred to a 96-well plate coated with feeder cells. Because the growth of GS cells is influenced by cell density, individual colonies were mixed with 1000 non-transfectred GS cells. Transduced cell populations were expanded by repeating G418 selection and mixing procedures until all colonies consisted of EGFP-expressing cells.
Transplantation
Cultured cells were transplanted into 5-to 10-day-old WBB6F1-W/W v (W) pups (Japan SLC). The colonies were dissociated by trypsin digestion, and approximately 2 l of each donor cell suspension (ϳ10 5 cells/testis) was injected into the seminiferous tubules of a W pup's recipient testis through the efferent duct [16] . At least six males were transplanted per GS cell clone. Recipient mice were placed on ice to cause hypothermiainduced anesthesia [20] . The different major histocompatibility complex (MHC) haplotype of the cultured cells necessitated giving the recipient mice 50 g anti-CD4 antibody (GK1.5) intraperitoneally on Days 0, 2, and 4 after transplantation to induce tolerance to the allogeneic donor cells [21] . At 4 to 5 wk after transplantation, the males were introduced to two or three wild-type female mice in order to generate progeny. The Institutional Animal Care and Use Committee of Kyoto University approved all of the animal experimentation protocols.
DNA Analysis
Recipient males were mated with wild-type females, and genomic DNA was isolated from tail samples of each offspring by phenol/chloroform extraction, followed by ethanol precipitation. Genomic DNA (10 g) isolated from tail tissue samples was digested overnight with Sph I, separated by electrophoresis, and blotted onto a nylon membrane (Hybond-N ϩ , Amersham Biosciences) according to conventional protocols. The fulllength EGFP cDNA was used as a probe for hybridization. The membrane was hybridized for 16 h at 65ЊC with a 32 P-labeled probe.
Analysis of Testis
Donor cell colonization was evaluated by observation of fluorescence under UV light [22] . This method allows the specific identification of donor germ cells, as the endogenous cells of the host testis do not fluoresce. The testes were fixed in 10% neutral-buffered formalin (Wako Pure Chemical Industries, Osaka, Japan), and processed for paraffin sectioning. All histological sections were stained with hematoxylin and eosin.
RESULTS
To set up a system for transfecting GS cells, GS cells were established from neonatal DBA/2 mice using a cocktail of cytokines [10] . Cells that had been cultured for 8-10 wk (8-13 passages) were used for transduction studies. At this stage, GS cell populations expand logarithmically; thus, 5 ϫ 10 8 GS cells could be collected from a newborn testis (composed of ϳ5 ϫ 10 5 cells). Only cultures in which GS cells appeared undifferentiated were selected for transfection (Fig. 1A, left top) . To gauge their efficacies for transfection, four conventional methodologies were assayed: electoroporation, lipofection, calcium phosphate-mediated transfection, and DEAE-dextran-mediated transfection. A neo-containing plasmid vector expresssing the EGFP gene (pCAG-EGFP2) was used to facilitate the assessment of the transfection efficiency. Assuming that GS * Results at 9 mo after transplantation; however, # 3765 was killed at 209 days for histological analysis (See Fig. 3 ). a Percentage of the surface seminiferous tubules in recipient testes filled by the injected cell suspension; cells were transplanted 12-24 passages after transfection. N.I., testis not injected with donor cells. b Time in days from transplantation of donor cells to birth of first transgenic progeny, which generally appeared in the first litter, except in one case (# 3768). c Numerator is the number of transgenic progeny; denominator is the total number of progeny from each recipient mouse. cells proliferated at the same speed after transfection, we determined the transfection efficiency using flow cytometry on the third day after transfection. Although electroporation proved the most efficient method of transduction (20.3 Ϯ 6.0%, nϭ3; mean Ϯ SEM.), only small numbers of cells (8.7 Ϯ 0.8%, nϭ3) subsequently survived the procedure (Fig. 1B) . In contrast, lipofection demonstrated both a relatively high transfection efficiency (3.9 Ϯ 2.5%, nϭ3) and a higher number of subsequent survivors of the transfected cells (95.8 Ϯ 7.0%, nϭ3) (Fig. 1A, right top) . We did not obtain sufficient numbers of EGFP-positive cells by either calcium phosphate-mediated (0.6 Ϯ 0.3%, nϭ3) or DEAEdextran-mediated methods (0.6 Ϯ 0.3%, nϭ3) to warrant further consideration. Owing to concerns that adverse culture condition after electroporation might negatively affect GS cell culture, lipofection was selected as the optimal methodology for clonal expansion. After G418 selection, isolated single colonies of undifferentiated GS cells were picked by micromanipulation and transferred to individual wells of a 96-well plate for clonal expansion. To facilitate clonal proliferation, individual colonies were mixed with 1000 non-transfectred GS cells. We used this procedure because we did not obtain any clones when 100 GS cell colonies were cultured without nontransfected GS cells. A total of 180 clones were picked, and 35 (19.4%) G418-resistant clones were successfully established. Five of these clones were randomly chosen for production of offspring by spermatogonial transplantation (Fig. 1A , left bottom, right bottom) [23] . No gross abnormalities in colony morphology or growth speed were noted after selection; cells were typically passaged every 5 days at dilutions of 1:3 to 1:5, while still in their undifferentiated state. The transfected clones could then be stored using a technique commonly employed to freeze somatic cells [24, 25] . The time scale required from initial transfection to transplantation was typically 2 to 3 mo.
To generate offspring from the transfected GS cell clones, single-cell suspensions of the colonies were microinjected into the seminiferous tubules of W mice. W mice are congenitally infertile but can produce offspring from transplanted donor cells [20] . By mating with wild-type females, recipient mice began producing offspring as early as 77 days after transplantation, and 14 of 51 (27%) recipients became fertile within 9 mo of transplantation. All progeny resulting from the mating were examined for the presence of the transgene by Southern blotting of tail DNA samples using an EGFP-specific probe. In total, 517 offspring from the 14 recipient mice were analyzed; of these, 251 of the offspring (48.5% of the F1 progeny) contained the transgene ( Table 1) . The offspring showed different degrees of fluorescence under UV light, and not all the offspring showed fluorescence despite the presence of the transgene. The donor transgene had inserted at the same site in DNA samples from progeny derived from a single recipient clone ( Fig. 2A) . However, each individual clone represented a unique integration event of the transgene (Fig. 2B) . Furthermore, transgenic offspring from different recipient males that had received the same clone all had identical patterns on Southern blots, confirming the common integration event (Fig. 2C) . At least four of the recipients continued to successfully produce offspring with the transgene at the same site of integration a year after transplantation, indicating the continued proliferation of donor stem cells. DNA from the transgenic offspring, digested with an enzyme that cuts once within the plasmid, produced a 7.4-kilobase (kb) band representative of the complete plasmid. Significantly, this band was present in all samples and was at elevated levels compared with all other bands, indicating that the transgene had integrated as multiple copies. Densitometric analysis showed that up to six copies of the transgenes were present in the genome (data not shown). EGFP-positive donor GS cells extensively colonized host recipient testis, as was evident under UV light (Fig. 3A) . The testes of the fertile males were significantly larger than those of the untreated, infertile males (Fig. 3B) , reflecting the extensive donor cell colonization. Histological analysis confirmed that complete spermatogenesis was occurring in the testis (Fig. 3C) , and that spermatozoa were present in the epididymides (Fig. 3D) . These results show that the donor GS cells proliferate monoclonally and colonized the recipient testes through spermatogonial transplantation.
The inheritance of the transgene occurred in a Mendelian fashion, and both male and female progeny could successfully transmit the transgene to the next generation (Fig. 3E) .
Tail DNA samples from F2 offspring demonstrated that the transgene was integrated into the same site as in the cultured cells and F1 offspring (Fig. 2D) , demonstrating that the transgene was stably transmitted to the following generation. To confirm whether the transgene is fully expressed in the F2 offspring, cells were collected from kidney and testis and were cultured in vitro in the presence of G418. Only cultures from EGFP-positive offspring showed resistance to G418. In contrast, cells from EGFP-negative mice died within 10 days of selection. The transgene was similarly expressed in germline cells, as GS cells established from the EGFP-positive males continued to proliferate in G418 containing medium (Fig. 3F) . The transgene continued to be expressed in the F3 generation in a manner similar to that in the F1 generation (data not shown). Thus, transfected GS cells can stably transmit the transgene through the germline to subsequent generations.
DISCUSSION
Although ES cells are now widely used for germline modification, ES cells with germline potential have only been obtained in mice [26] , which limits their application. Our results show that germline cells from testis could provide an alternative approach. There are several advantages associated with GS cell-based germline modification compared with conventional approaches. First, because GS cells are derived from postnatal testis, it is not necessary to sacrifice the conceptus or embryos. Second, because male founder animals can produce enormous numbers of transgenic spermatozoa [3] , the number of possible transgenic progeny far exceeds the comparative potential number achievable by female founders. Third, it is possible to obtain transgenic offspring at a higher efficiency. Typically, with conventional technologies, only 5-10% of the offspring will contain a transgene [27, 28] ; whereas, GS cellbased germline modification demonstrated significantly higher transfection efficiency, approaching ϳ50% in the experiments reported here. Finally, GS cells are stably committed to the germline and do not lose germ cell potential even after long-term culturing [10] . In contrast, ES cells often lose germ cell potential owing to differentiation or abnormal karyotype [29, 30] , which is difficult to predict before chimera formation [26] . The stable germline transmission of GS cells makes the procedure simple and more reliable. Thus, GS cells may overcome difficulties associated with conventional transgenic technologies.
The next obvious goal is to generate knockout animals using site-directed homologous recombination. Our experiments are encouraging because they demonstrate that GS cells will allow the in vitro selection that is necessary to obtain clones of desirable mutations. This ''gene targeting'' technology was initially developed in somatic cells [31, 32] , and is widely used in ES cells [18, 33] . However, very little is known about the efficiency of homologous recombination in tissue-specific stem cells. Because stem cells are significantly more resistant to cytotoxic damage than are differentiating progenitors, they may possess different DNA repair machinery [34] , which may have an impact on the efficiency of homologous recombination. Current GS cell culture conditions may also be problematic, because the clonal growth of GS cells requires the presence of other GS cells. Nonetheless, the induction of specific changes in DNA is an important goal in stem cell-based technology, and the GS cell system will provide a useful model to determine the feasibility of such a procedure. Possibly it will lead to new developments in animal transgenics and gene therapy.
